6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Mental Health
Mental health relates to a person's cognitive, behavioural, emotional, and physiological well-being. It refers to the process of how we think, feel, and behave. It is a vital aspect at all stages of life, from childhood to adulthood. If a person has normal mental health, he or she will act in accordance with his or her emotions and state of mind. If it is harmed, it can result in a variety of mental diseases and disorders, such as:
- Anxiety
- Clinical Depression
- Bipolar Disorder
- Dementia
- Obsessive-compulsive disorder
- Autism
- Post-traumatic stress disorder
The following variables contribute to mental health problems: - Biological factors, such as genes or brain chemistry
- Life experiences, such as trauma or abuse
- A family history of mental health issues
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States